
ATS Q1 Earnings Call Highlights
MarketBeat
公開日時: Aug 08, 2026, 08:05 AM GMT+9
Sentiment Analysis
ATS reported a weaker fiscal Q1: Adjusted revenue fell 5.2% year over year to CAD 698 million, adjusted operating earnings declined 13.4% to CAD 68.1 million, and bookings dropped 5.3% to CAD 656 million. Backlog stood at approximately CAD 1.9 billion. An 18-month fixed-cost transformation program aims to generate CAD 60 million–CAD 70 million in annualized savings, including about CAD 20 million from initial European facility consolidation. Management expects the program to contribute roughly 250 basis points of margin improvement and help ATS reach or exceed its 15% operating-margin target. Radiopharmaceuticals and energy remain key growth drivers, while quarterly results face volatility from long-cycle project timing. ATS expects second-quarter revenue of CAD 660 million–CAD 700 million and anticipates stronger margins in the second half of fiscal 2027 as backlog converts and cost actions take effect.
ATS NYSE: ATS reported lower fiscal first-quarter revenue and operating earnings as it navigated a reduced opening backlog, planned declines in transportation-related work and timing shifts in large customer awards. Management said it is launching an 18-month fixed-cost transformation program intended to support its longer-term goal of reaching—and potentially exceeding—a 15% operating margin. For the first quarter of fiscal 2027, adjusted revenue declined 5.2% year over year to CAD 698 million. Adjusted earnings from operations fell 13.4% to CAD 68.1 million, while adjusted earnings per share were CAD 0.35. The company said the lower earnings primarily reflected reduced revenue, with benefits from cost actions still to come. Order bookings totaled CAD 656 million, down 5.3% from the prior-year quarter, mainly because the comparison period included large nuclear project awards. ATS ended the quarter with approximately CAD 1.9 billion in backlog.
Fixed-cost program targets margin expansion Chief Executive Officer Doug Wright said he completed a portfolio review and site assessments across the business after joining ATS, identifying opportunities to simplify operations, improve efficiency and raise returns on invested capital. The company has initiated an 18-month Fixed-Cost Transformation Program focused on reducing facility overhead, indirect expenses and SG&A costs. The initial phase centers on Europe, where ATS identified excess capacity and operating infrastructure that it said was not generating returns consistent with its requirements. ATS plans to consolidate certain European facilities and transfer selected technical capabilities to other company locations with available capacity. Wright said the first European phase is expected to produce annualized savings of about CAD 20 million, representing roughly 30% of the savings opportunity anticipated from the overall fixed-cost program. During the analyst question-and-answer session, Wright indicated that the broader program implies approximately CAD 60 million to CAD 70 million of potential annualized savings. He said the initiatives would be “materially complete” within 18 months, though the full savings run rate would accrue over a longer period. Management said roughly half of the improvement needed to reach the company’s 15% operating-margin target is expected to come from the fixed-cost program. The remaining improvement is expected from higher-margin aftermarket services, commercial discipline, innovation and wider application of ATS’s business-management tools. Wright told analysts that the transformation is intended to create a more flexible cost structure without limiting investment in growth areas such as radiopharmaceuticals and nuclear e...
Source: MarketBeat
個別の投資に関する推奨やアドバイスを提供することを意図しておりません。ここで述べられている意見や見解は、あくまでも各記事の個人的見解です。